Page results
-
Dr Roser Vega is a consultant gastroenterologist and interventional colonoscopist. She leads the University College Hospital interventional colonoscopy service, providing advanced diagnosis and endoscopic treatment for colonic polyps and early colon cancers. She also delivers specialist care to patients with complex inflammatory bowel disease.
-
Zero carbon, virtual appointments, specialist advice in primary care settings, thousands using online services, remote monitoring and digitising admin tasks: these are just some of the ways we will achieve patient-centred, integrated, excellent care for our patients as set out in our new outpatient strategy.
-
The UCLH play and youth services team provides therapeutic, diagnostic, developmental and specialised play interventions to help support children and young people during their time at UCLH.
-
A safeguarding clinic dedicated to the long term needs of children and young people who have problems related to Sexual, gynaecological or genito-urinary health, Complex maltreatment including sexual abuse, female genital mutilation, factitious illness and related issues. We also see unaccompanied children, refugees and looked after children.
-
The Teenage and Young Adults Cancer Service looks after people aged from 13 to 24, who may have a wide range of cancers and some non-cancerous conditions.
-
The Lighthouse is a facility in north London, set up in partnership with organisations in the voluntary and public sectors to provide a safe space to support children and young people, from 0-18, in their recovery from sexual abuse or exploitation.
-
UCLH has continued to achieve excellent results in the National Inpatient Survey, with patients rating their overall care as 8.7 out of 10 – the top score amongst our London peers.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
Our non-emergency patient transport service is provided by G4S. G4S may use approved external sub-contractors to meet the demand of the service and/or the specific needs of our patients.
-
The COVID Medicines Delivery Unit (CMDU gives new COVID-19 treatments for patients at highest risk in the community from the NCL sector. These treatments involve intravenous infustion of neutralising monoclonal antibodies (nMABs) or oral antiviral treatments, which are given to high-risk patients who have had a positive PCR test.
